Recent technological advances include next‑gen transcatheter systems (e.g., SAPIEN 3 Ultra RESILIA, Evolut FX+, Navitor Vision) and early-stage living valves that integrate and grow with the patient—to reduce reoperations . https://www.datamintelligence.com/research-report/heart-valve-devices-market